Abstract | BACKGROUND: METHODS: We assessed plasma levels of von Willebrand factor (vWF) and thrombomodulin (TM) and the blood levels of endothelial progenitor cells (EPCs) and circulating progenitor cells (CPCs) in 49 CADASIL patients and 49 age-matched controls and their association with clinical/functional and neuroimaging features. RESULTS: In multivariate analysis, CADASIL patients had significantly higher vWF and lower EPC levels. TM levels were similar in the 2 groups. CADASIL patients with a more severe clinical phenotype (history of stroke or dementia) presented lower CPC levels in comparison with patients with a milder phenotype. On correlation analysis, lower CPC levels were associated with worse performances on neuropsychological, motor and functional tests, and with higher lesion load on brain magnetic resonance imaging (degree of leukoencephalopathy and number of lacunar infarcts). CONCLUSIONS: This is the first CADASIL series in which multiple circulating biomarkers have been studied. Our findings support previous studies on the presence and the possible modulating effect of endothelial impairment in the disease. Furthermore, our research data suggest that blood CPCs may be markers of disease severity.
|
Authors | Francesca Pescini, Ida Donnini, Francesca Cesari, Serena Nannucci, Raffaella Valenti, Valentina Rinnoci, Anna Poggesi, Anna Maria Gori, Betti Giusti, Angela Rogolino, Alessandra Carluccio, Silvia Bianchi, Maria Teresa Dotti, Antonio Federico, Maurizio Balestrino, Enrico Adriano, Rosanna Abbate, Domenico Inzitari, Leonardo Pantoni |
Journal | Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association
(J Stroke Cerebrovasc Dis)
Vol. 26
Issue 4
Pg. 823-833
(Apr 2017)
ISSN: 1532-8511 [Electronic] United States |
PMID | 27876311
(Publication Type: Journal Article)
|
Copyright | Copyright © 2017 National Stroke Association. Published by Elsevier Inc. All rights reserved. |
Chemical References |
- Antigens, CD
- Biomarkers
- THBD protein, human
- Thrombomodulin
- von Willebrand Factor
- Vascular Endothelial Growth Factor Receptor-2
|
Topics |
- Adult
- Aged
- Antigens, CD
(metabolism)
- Biomarkers
(blood)
- Brain
(diagnostic imaging, pathology)
- CADASIL
(blood, pathology)
- Case-Control Studies
- Endothelial Progenitor Cells
(pathology)
- Female
- Flow Cytometry
- Humans
- Magnetic Resonance Imaging
- Male
- Middle Aged
- Risk Factors
- Thrombomodulin
(blood)
- Vascular Endothelial Growth Factor Receptor-2
(blood)
- von Willebrand Factor
(metabolism)
|